Research - International Journal of Medical Research & Health Sciences ( 2022) Volume 11, Issue 12
An Alarming Turn of Obsessive-Compulsive Disorder (OCD) Among the Youth of Turkey
Muhammad Arslan*Muhammad Arslan, Middle East Technical University, Ankara, Turkey, Email: Muhammad.arslan@metu.edu.tr
Received: 01-Dec-2022, Manuscript No. ijmrhs-22-81953; Editor assigned: 05-Dec-2022, Pre QC No. ijmrhs-22-81953 (PQ); Reviewed: 08-Dec-2022, QC No. ijmrhs-22-81953 (Q); Revised: 10-Dec-2022, Manuscript No. ijmrhs-22-81953 (R); Published: 30-Dec-2022
Abstract
The study aimed to screen Obsessive-Compulsive Disorder (OCD); a progressively burdensome, highly prevalent, untreated, poorly detectable psychic condition in the general population of Turkey, of around 401 participants, mainly focusing on two parameters (Age groups and Gender). Screening Questions were asked through online questionnaires regarding different attributes of the disorder. In this review, we consider a screening measure, a Questionnaire that is not designed to diagnose OCD but to help people determine and inform mental health professionals for further discussion about diagnosis and treatment plan. The occurrence of OCD in youth especially females of age ranging from 20 years to 30 years is noticeable due to high inflation and the recent pandemic. Questionnaires for screening in fields where affected individuals congregate seem persuasive, although evidence that screening is socially & clinically beneficial in terms of reducing morbidity is still lacking. People seem to be unaware of the sign & symptoms, its progression, and hence the severity of the disease, as it stays undetected due to lack of proper instruments, so evaluation of screening tools and their use in reducing disease burden are important areas for further research.
Keywords
Obsessive-Compulsive Disorder (OCD), Turkey, Psychic
Introduction
Obsessive-Compulsive Disorder (OCD) is a stereotypical, common but misdiagnosed and poorly recognized neuropsychiatric disorder characterized by repetitive behaviours, recurrent distressing and undesirable thoughts, or mental ceremonials to alleviate anxiety [1]. It consists of two terms Obsession and Compulsion. Obsessions are repeated thoughts, mental images, or cravings that cause anxiety e.g. Fear of germs and contamination, while on the other hand Compulsion are reiterating manners a doings that individual suffering e.g
Excessive washing and cleaning hands, ordering an arranging things in a particular way, numeration of things, to inspect if the door has been locked [2]. OCD is more common in young people because it is under-recognized and untreated, the reason behind this is children at this age find the symptoms embarrassing and they don’t disclose them until they are asked [3]. Half of the people develop symptoms before 20 years, symptoms develop after the age of 35 is unusual [4]. Symptoms are related to tics, jerks e.g. motor ticks which include sudden, brief repetitive movements like shoulder shrug and most often, eye blinking, vocal tics which usually include grunting sounds, sniffing, and clearing of the throat [2]. Lifetime tic disorder has been seen in 10% to 40% of individuals suffering from OCD [5]. A most reliable four-factor structure was found by a meta-analytic revision of symptom structures, the teams encircled a “taboo thoughts issue”, a “symmetry factor”, a “cleaning factor” and a “hoarding factor”. The Taboo thoughts factor was related to distressing and intrusive thoughts of religious, sexual, or violent. The symmetry issue correlates with obsessions involving symmetry, arrangement, and numeration additionally as ordering and repetition compulsions. The cleaning factor was obsessions and compulsions relating to dirt, contamination, and cleansing. The hoarding factor was an obsession and compulsion related only to hoarding [6]. Neurophysiological findings of OCD show cognitive impairment in attention, visuospatial skills, and nonverbal memory [7]. Structural Neuroimaging and functional studies of the brain implicate the basal ganglia, Posterior Cingulate Cortex (PCC), Insula, Prefrontal Cortex (PFC) and while Neurochemical and Genetic studies implicate monoamine neurotransmitters and glutamate, especially dopamine and serotonin [8]. Referring to an underrepresentation, the lifetime prevalence of OCD is around 2.3% because people are unaware of symptoms and they report it when it becomes severe [9]. In pediatric OCD, around 40% qualify for remission and around 40% still have OCD in adulthood [10]. It is most often accompanied by secrecy and shame leading to an increased risk of suicide. OCD when not treated becomes chronic and runs a lifelong course with intensity fluctuating but rarely disappearing [11]. Symptoms are not permanent or persistent, they come and go, and they are usually triggered by their obsessions, stress, alcohol, or drugs like tranquilizers. It is usually misled with other mental disorders like anxiety and schizophrenia. In 2006, Obsessive-Compulsive Related Disorders (OCRDs) work group inference of meeting, the Research Planning Agenda of Diagnostic and Statistical Manual (5th Edition) (DSM-V) shows that OCD must be omitted from Anxiety Disorders which aligned with the present International Classification of Mental Disorder (ICD-10) as a distinguished category, although according to ICD-10 both lies under the same roof of “neurotic, stressâ?ÂÂrelated, and somatoform disorders,” [12]. Being poorly recognized, only a minority of patients receive the proper timely treatment [10]. Risk factors of OCD include Genetics (higher risk if the first cousin has a child with congenital OCD), Brain functioning and structure (dissimilarities in FC and subcortical parts of the brain and congenital serotonin deficiency), and Environment, PANDAS has been suspected to cause OCD in children [2]. The serotonin transporter gene, h-SERT, the mutation has been found as the cause of OCD in unrelated families [13]. The serotonin receptor 2B gene (HTR2B; MIM 601122) is a pharmacologically appreciable candidate gene in the early onset of OCD [14]. Comorbidities associated with OCD include problems mentioned in Figure 1 [15]. Causes include alleviated fractional inhomogeneity in (AMI) anterior midline tracts, alleviated volumes of dorsolateral PFC connected to administrative function, and increased white matter volume [16,17]. Alleviated amount of Dopamine binding in the striatum [18]. Olanzapine (Zyprexa) like Atypical antipsychotics has been turned out to cause a de-novo type of OCD [19]. OCD has been ranked as of the twenty leading causes of disability by the performs in response to an obsession World Health Organization WHO. Clinical studies indicate that appreciable psychosocial morbidity is related to OCD as compared to alternative diseases [11]. All aspects of Quality of Life (QOL) and physiological functions are markedly affected in the person with OCD and are associated with depression severity and OCD severity [20]. Diagnosis includes Y-BOCS as a rating scale to estimate the severity of the disease [21]. First-line therapies that are recommended for OCD are ERP, CBT, and SSRI [22]. CBT involves accumulated exposure to the issues whereas forbidding the incidence of repetitive behaviours [23]. Fluvoxamine FLV proved to be a safe and effective treatment as it improved the symptoms of depressed as well as non-depressed patients [24]. Naturally occurring inositol has been suggested to be used as a treatment for OCD [25]. OCD symptoms might improve from µ-opioids, such as hydrocodone and tramadol [26]. NICE guidelines in 2006, put forward antipsychotic treatment for OCD that did not ameliorate with SSRI [27]. In severe and refractory cases ECT has been found to have effectiveness [28].
Figure 1. Percentile presentation of comorbid disorders of OCD
Current Study
This study aims to screen for Obsessive-Compulsive Disorder (OCD) among the youth of Turkey. We hypothesize that the youth of Turkey is suffering from OCD, especially after the high inflation and price hikes in almost every sector such as education, food, and health. We hypothesize that the main group of people that are suffering right now because of the above-mentioned reason is youth, especially the students studying at various universities in Turkey. Although, young or adult students are unlikely to be affected by inflation the responsibility of starting their career in Turkey as well as difficulty in making future planning is hitting in a very severe way to these people due to inflation as well as the damage caused by COVID-19 in recent years. All of these stressful situations have triggered mental disorders among people, especially OCD. We have focused on and compared our study with the past prevalence studies of OCD among US adults (2001-2003). Due to all these hypotheses, we expect the results of our study will be much more alarming, especially among the youth. To achieve our purpose, we evaluated the mental perception of distress and focused on the clinical analysis of psychotherapists via the results of a questionnaire.
Method
Aim
A cross-sectional study was conducted for the entire research population. The study site was Middle East Technical University, Ankara, Turkey. The study populace was the general population in Turkey irrespective of their history, ethnicity, and sociocultural belief. An organized, self-administered Questionnaire containing closeended questions was used as the screening tool for the Identification of the disorder. Using the cross-sectional study design data was collected using an online questionnaire. The Questionnaire used is provided at the end of the Methodology. The method includes a screening of the general population or around 401 participants. Concerning genders e.g. male and female and concerning different age groups e.g. 20 years to 30 years, 31 years to 40 years, 41 years to 50 years, and greater than 50 years. Data was collected using an online questionnaire designed using google forms and the link was shared via distinctive social media platforms. The screening questions were asked of the individuals to help them recognize and inform health professionals of further guidelines regarding the diagnosis as well as the treatment. Moreover, the frequency and intensity of OCD are also assessed by using this screening measure. Data collected was calculated by using IBM SPSS Statistics 25). Data analysis consists of frequency analysis, reliability analysis, and cross-tabulation for Chi-Square (x2 ) by age and gender, and Fisher’s Exact test by Age (where cell counted less than 5 in a person’s chi-square) to test for statistical significance. The study took around 4 months duration from April 2022 to July 2022. The questionnaire included a written consent form that stated all the necessary information regarding the purpose of the study and ensured that the data provided by the patient will be kept private and not be misused in any illegal activity.
Result
Based on data collected through questionnaire responses the descriptive statistics are presented in Table 1. It was seen that Females of the age group 20 years to 30 years are more susceptible (Figure 2 and 3). The past prevalence studies of OCD among U.S Adults (2001-2003) did confirm the statistics. According to the responses taken through the questionnaire, it has been seen that people did seem persuasive but the evidence of the screening process, being helpful clinically and socially lacking in reducing the morbidity and burden of disease (Table 2 and 3).
| Question no. | Options | Age Range | Frequency | Percentage(%) | p-value |
|---|---|---|---|---|---|
| Question 1 | Yes | 20 years to 30 years | 220 | 79.10% | 0.536 |
| 31 years to 40 years | 39 | 14.00% | |||
| 41 years to 50 years | 10 | 3.60% | |||
| >50 years | 9 | 3.20% | |||
| No | 20 years to 30 years | 98 | 79.70% | ||
| 31 years to 40 years | 19 | 15.40% | |||
| 41 years to 50 years | 5 | 4.10% | |||
| >50 years | 1 | 0.80% | |||
| Question 2 | Yes | 20 years to 30 years | 178 | 76.40% | 0.286 |
| 31 years to 40 years | 37 | 15.90% | |||
| 41 years to 50 years | 10 | 4.30% | |||
| >50 years | 8 | 3.40% | |||
| No | 20 years to 30 years | 140 | 83.30% | ||
| 31 years to 40 years | 21 | 12.50% | |||
| 41 years to 50 years | 5 | 3.00% | |||
| >50 years | 2 | 1.20% | |||
| Question 3 | Yes | 20 years to 30 years | 202 | 76.80% | 0.374 |
| 31 years to 40 years | 42 | 16.00% | |||
| 41 years to 50 years | 11 | 4.20% | |||
| >50 years | 8 | 3.00% | |||
| No | 20 years to 30 years | 116 | 84.10% | ||
| 31 years to 40 years | 16 | 11.60% | |||
| 41 years to 50 years | 4 | 2.90% | |||
| >50 years | 2 | 1.40% | |||
| Question 4 | Yes | 20 years to 30 years | 174 | 74.00% | 0.017 |
| 31 years to 40 years | 41 | 17.40% | |||
| 41 years to 50 years | 12 | 5.10% | |||
| >50 years | 8 | 3.40% | |||
| No | 20 years to 30 years | 144 | 86.70% | ||
| 31 years to 40 years | 17 | 10.20% | |||
| 41 years to 50 years | 3 | 1.80% | |||
| >50 years | 2 | 1.20% | |||
| Question 5 | Yes | 20 years to 30 years | 187 | 79.60% | 0.687 |
| 31 years to 40 years | 36 | 15.30% | |||
| 41 years to 50 years | 7 | 3.00% | |||
| >50years | 5 | 2.10% | |||
| No | 20 years to 30 years | 131 | 78.90% | ||
| 31 years to 40 years | 22 | 13.30% | |||
| 41 years to 50 years | 8 | 4.80% | |||
| >50 years | 5 | 3.00% | |||
| Question 6 | Yes | 20 years to 30 years | 227 | 80.80% | 0.058 |
| 31years to 40 years | 33 | 11.60% | |||
| 41 years to 50 years | 13 | 4.60% | |||
| >50 years | 8 | 2.80% | |||
| No | 20 years to 30 years | 91 | 75.80% | ||
| 31 years to 40 years | 25 | 20.80% | |||
| 41 years to 50 years | 2 | 1.70% | |||
| >50 years | 2 | 1.70% | |||
| Question 7 | Yes | 20 years to 30 years | 171 | 77.00% | 0.231 |
| 31 years to 40 years | 36 | 16.20% | |||
| 41 years to 50 years | 7 | 3.20% | |||
| >50 years | 8 | 3.60% | |||
| No | 20 years to 30 years | 147 | 82.10% | ||
| 31 years to 40 years | 22 | 12.30% | |||
| 41 years to 50 years | 8 | 4.50% | |||
| >50 years | 2 | 1.10% | |||
| Question 8 | Yes | 20 years to 30 years | 170 | 77.60% | 0.033 |
| 31 years to 40 years | 35 | 16.00% | |||
| 41 years to 50 years | 5 | 2.30% | |||
| >50 years | 9 | 4.10% | |||
| No | 20 years to 30 years | 148 | 81.30% | ||
| 31 years to 40 years | 23 | 12.60% | |||
| 41 years to 50 years | 10 | 5.50% | |||
| >50 years | 1 | 0.50% | |||
| Question 9 | Yes | 20 years to 30 years | 178 | 75.70% | 0.153 |
| 31 years to 40 years | 38 | 46.20% | |||
| 41 years to 50 years | 11 | 4.70% | |||
| >50 years | 8 | 3.40% | |||
| No | 20 years to 30 years | 140 | 84.30% | ||
| 31 years to 40 years | 20 | 12.00% | |||
| 41 years to 50 years | 4 | 2.40% | |||
| >50 years | 2 | 1.20% | |||
| Question 10 | Yes | 20 years to 30 years | 205 | 77.90% | 0.345 |
| 31 years to 40 years | 40 | 15.20% | |||
| 41 years to 50 years | 9 | 3.40% | |||
| >50 years | 9 | 9 3.4% | |||
| No | 20 years to 30 years | 113 | 81.90% | ||
| 31 years to 40 years | 18 | 13.00% | |||
| 41 years to 50 years | 6 | 4.30% | |||
| >50 years | 1 | 0.70% | |||
| Question 11 | Yes | 20 years to 30 years | 208 | 79.10% | 0.402 |
| 31 years to 40 years | 37 | 14.10% | |||
| 41 years to 50 years | 9 | 3.40% | |||
| >50 years | 9 | 3.40% | |||
| No | 20 years to 30 years | 110 | 79.70% | ||
| 31 years to 40 years | 21 | 15.20% | |||
| 41 years to 50 years | 6 | 4.30% | |||
| >50 years | 1 | 0.70% | |||
| Question 12 | Yes | 20 years to 30 years | 157 | 74.10% | 0.017 |
| 31 years to 40 years | 36 | 17.00% | |||
| 41 years to 50 years | 10 | 4.70% | |||
| >50 years | 9 | 4.20% | |||
| No | 20 years to 30 years | 161 | 85.20% | ||
| 31 years to 40 years | 22 | 11.60% | |||
| 41 years to 50 years | 5 | 2.60% | |||
| >50 years | 1 | 0.50% | |||
| Question 13 | Yes | 20 years to 30 years | 173 | 77.60% | 0.307 |
| 31 years to 40 years | 35 | 15.70% | |||
| 41 years to 50 years | 11 | 4.90% | |||
| >50 years | 4 | 1.80% | |||
| No | 20 years to 30 years | 145 | 81.50% | ||
| 31 years to 40 years | 23 | 12.90% | |||
| 41 years to 50 years | 4 | 22.20% | |||
| >50 years | 6 | 3.40% | |||
| Question 14 | Yes | 20 years to 30 years | 207 | 81.20% | 0.143 |
| 31 years to 40 years | 31 | 12.20% | |||
| 41 years to 50 years | 12 | 4.70% | |||
| >50 years | 5 | 2.00% | |||
| No | 20 years to 30 years | 111 | 76.00% | ||
| 31 years to 40 years | 27 | 18.50% | |||
| 41 years to 50 years | 3 | 2.10% | |||
| >50 years | 5 | 3.40% | |||
| Question 15 | Yes | 20-30years | 192 | 78.40% | 0.899 |
| 31 years to 40 years | 37 | 15.10% | |||
| 41 years to 50 years | 9 | 3.70% | |||
| >50 years | 7 | 2.90% | |||
| No | 20 years to 30 years | 126 | 80.80% | ||
| 31 years to 40 years | 21 | 13.50% | |||
| 41 years to 50 years | 6 | 3.80% | |||
| >50 years | 3 | 1.90% |
Figure 2. Descriptive statistics of demographic data
Figure 3. The prevalence of the obsessive-compulsive disorder among American adults last year (2001-2003)[29]
| Question no. | Options | Female | Male | p-value | ||
|---|---|---|---|---|---|---|
| Question 1 | Yes | 191 | 68.70% | 87 | 31.30% | 0.01 |
| No | 68 | 55.50% | 55 | 44.70% | ||
| Question 2 | Yes | 170 | 73.00% | 63 | 27% | 0.01 |
| No | 89 | 53% | 79 | 47% | ||
| Question 3 | Yes | 175 | 66.50% | 88 | 33.50% | 0.259 |
| No | 84 | 60.90% | 54 | 39.10% | ||
| Question 4 | Yes | 161 | 68.50% | 74 | 31.50% | 0.051 |
| No | 98 | 59.00% | 68 | 41.00% | ||
| Question 5 | Yes | 161 | 68.50% | 74 | 31.50% | 0.051 |
| No | 98 | 59.00% | 68 | 41.00% | ||
| Question 6 | Yes | 179 | 63.70% | 102 | 36.30% | 0.57 |
| No | 80 | 66.70% | 40 | 33.30% | ||
| Question 7 | Yes | 151 | 68.00% | 71 | 32.00% | 0.11 |
| No | 108 | 60.30% | 71 | 39.70% | ||
| Question 8 | Yes | 145 | 66.20% | 74 | 33.80% | 0.456 |
| No | 114 | 62.60% | 68 | 37.40% | ||
| Question 9 | Yes | 153 | 65.10% | 82 | 34.90% | 0.796 |
| No | 106 | 63.90% | 60 | 36.10% | ||
| Question 10 | Yes | 175 | 66.50% | 88 | 33.50% | 0.259 |
| No | 84 | 60.90% | 54 | 39.10% | ||
| Question 11 | Yes | 167 | 63.50% | 96 | 36.50% | 0.528 |
| No | 92 | 66.70% | 46 | 33.30% | ||
| Question 12 | Yes | 133 | 62.70% | 79 | 37.30% | 0.411 |
| No | 126 | 66.70% | 63 | 33.30% | ||
| Question 13 | Yes | 138 | 61.90% | 85 | 38.10% | 0.205 |
| No | 121 | 68.00% | 57 | 32.00% | ||
| Question 14 | Yes | 163 | 63.90% | 92 | 36.10% | 0.712 |
| No | 96 | 65.80% | 50 | 34.80% | ||
| Question 15 | Yes | 155 | 63.30% | 90 | 36.70% | 0.487 |
| No | 104 | 66.70% | 52 | 33.30% | ||
| Question no. | Options | Age Range | Frequency | Percentage(%) | p-value |
|---|---|---|---|---|---|
| Question 1 | Yes | 20 years to 30 years | 220 | 79.10% | 0.571 |
| 31 years to 40 years | 39 | 14.00% | |||
| 41 years to 50 years | 10 | 3.60% | |||
| >50 years | 9 | 3.20% | |||
| No | 20 years to 30 years | 98 | 79.70% | ||
| 31 years to 40 years | 19 | 15.40% | |||
| 41 years to 50 years | 5 | 4.10% | |||
| >50 years | 1 | 0.80% | |||
| Question 2 | Yes | 20 years to 30 years | 178 | 76.40% | 0.313 |
| 31 years to 40 years | 37 | 15.90% | |||
| 41 years to 50 years | 10 | 4.30% | |||
| >50 years | 8 | 3.40% | |||
| No | 20 years to 30 years | 140 | 83.30% | ||
| 31 years to 40 years | 21 | 12.50% | |||
| 41 years to 50 years | 5 | 3.00% | |||
| >50 years | 2 | 1.20% | |||
| Question 3 | Yes | 20 years to 30 years | 202 | 76.80% | 0.428 |
| 31 years to 40 years | 42 | 16.00% | |||
| 41 years to 50 years | 11 | 4.20% | |||
| >50 years | 8 | 3.00% | |||
| No | 20 years to 30 years | 116 | 84.10% | ||
| 31 years to 40 years | 16 | 11.60% | |||
| 41 years to 50 years | 4 | 2.90% | |||
| >50 years | 2 | 1.40% | |||
| Question 4 | Yes | 20 years to 30 years | 174 | 74.00% | 0.017 |
| 31 years to 40 years | 41 | 17.40% | |||
| 41 years to 50 years | 12 | 5.10% | |||
| >50 years | 8 | 3.40% | |||
| No | 20 years to 30 years | 144 | 86.70% | ||
| 31 years to 40 years | 17 | 10.20% | |||
| 41 years to 50 years | 3 | 1.80% | |||
| >50 years | 2 | 1.20% | |||
| Question 5 | Yes | 20 years to 30 years | 187 | 79.60% | 0.676 |
| 31 years to 40 years | 36 | 15.30% | |||
| 41 years to 50 years | 7 | 3.00% | |||
| >50 years | 5 | 2.10% | |||
| No | 20 years to 30 years | 131 | 78.90% | ||
| 31 years to 40 years | 22 | 13.30% | |||
| 41 years to 50 years | 8 | 4.80% | |||
| >50 years | 5 | 3.00% | |||
| Question 6 | Yes | 20 years to 30 years | 227 | 80.80% | 0.064 |
| 31 years to 40 years | 33 | 11.60% | |||
| 41 years to 50 years | 13 | 4.60% | |||
| >50 years | 8 | 2.80% | |||
| No | 20 years to 30 years | 91 | 75.80% | ||
| 31 years to 40 years | 25 | 20.80% | |||
| 41 years to 50 years | 2 | 1.70% | |||
| >50 years | 2 | 1.70% | |||
| Question 7 | Yes | 20 years to 30 years | 171 | 77.00% | 0.237 |
| 31 years to 40 years | 36 | 16.20% | |||
| 41 years to 50 years | 7 | 3.20% | |||
| >50 years | 8 | 3.60% | |||
| No | 20 years to 30 years | 147 | 82.10% | ||
| 31 years to 40 years | 22 | 12.30% | |||
| 41 years to 50 years | 8 | 4.50% | |||
| >50 years | 2 | 1.10% | |||
| Question 8 | Yes | 20 years to 30 years | 170 | 77.60% | 0.031 |
| 31 years to 40 years | 35 | 16.00% | |||
| 41 years to 50 years | 5 | 2.30% | |||
| >50 years | 9 | 4.10% | |||
| No | 20 years to 30 years | 148 | 81.30% | ||
| 31 years to 40 years | 23 | 12.60% | |||
| 41 years to 50 years | 10 | 5.50% | |||
| >50 years | 1 | 0.50% | |||
| Question 9 | Yes | 20 years to 30 years | 178 | 75.70% | 0.163 |
| 31 years to 40 years | 38 | 46.20% | |||
| 41 years to 50 years | 11 | 4.70% | |||
| >50 years | 8 | 3.40% | |||
| No | 20 years to 30 years | 140 | 84.30% | ||
| 31 years to 40 years | 20 | 12.00% | |||
| 41 years to 50 years | 4 | 2.40% | |||
| >50 years | 2 | 1.20% | |||
| Question 10 | Yes | 20 years to 30 years | 205 | 77.90% | 0.362 |
| 31 years to 40 years | 40 | 15.20% | |||
| 41 years to 50 years | 9 | 3.40% | |||
| >50 years | 9 | 9 3.4% | |||
| No | 20 years to 30 years | 113 | 81.90% | ||
| 31 years to 40 years | 18 | 13.00% | |||
| 41 years to 50 years | 6 | 4.30% | |||
| >50 years | 1 | 0.70% | |||
| Question 11 | Yes | 20 years to 30 years | 208 | 79.10% | 0.414 |
| 31 years to 40 years | 37 | 14.10% | |||
| 41 years to 50 years | 9 | 3.40% | |||
| >50 years | 9 | 3.40% | |||
| No | 20 years to 30 years | 110 | 79.70% | ||
| 31 years to 40 years | 21 | 15.20% | |||
| 41 years to 50 years | 6 | 4.30% | |||
| >50 years | 1 | 0.70% | |||
| Question 12 | Yes | 20 years to 30 years | 157 | 74.10% | 0.015 |
| 31 years to 40 years | 36 | 17.00% | |||
| 41 years to 50 years | 10 | 4.70% | |||
| >50 years | 9 | 4.20% | |||
| No | 20 years to 30 years | 161 | 85.20% | ||
| 31 years to 40 years | 22 | 11.60% | |||
| 41 years to 50 years | 5 | 2.60% | |||
| >50 years | 1 | 0.50% | |||
| Question 13 | Yes | 20 years to 30 years | 173 | 77.60% | 0.313 |
| 31 years to 40 years | 35 | 15.70% | |||
| 41 years to 50 years | 11 | 4.90% | |||
| >50 years | 4 | 1.80% | |||
| No | 20 years to 30 years | 145 | 81.50% | ||
| 31 years to 40 years | 23 | 12.90% | |||
| 41 years to 50 years | 4 | 22.20% | |||
| >50 years | 6 | 3.40% | |||
| Question 14 | Yes | 20 years to 30 years | 207 | 81.20% | 0.141 |
| 31 years to 40 years | 31 | 12.20% | |||
| 41 years to 50 years | 12 | 4.70% | |||
| >50 years | 5 | 2.00% | |||
| No | 20 years to 30 years | 111 | 76.00% | ||
| 31 years to 40 years | 27 | 18.50% | |||
| 41 years to 50 years | 3 | 2.10% | |||
| >50 years | 5 | 3.40% | |||
| Question 15 | Yes | 20 years to 30 years | 192 | 78.40% | 0.923 |
| 31 years to 40 years | 37 | 15.10% | |||
| 41 years to 50 years | 9 | 3.70% | |||
| >50 years | 7 | 2.90% | |||
| No | 20 years to 30 years | 126 | 80.80% | ||
| 31 years to 40 years | 21 | 13.50% | |||
| 41 years to 50 years | 6 | 3.80% | |||
| >50 years | 3 | 1.90% |
Discussion
Study statistics and results are alarming and require professional attention as there is such a high count of patients suffering from OCD. The main cause behind this seems to be untreated OCD, which tells that due to some factors people don’t get proper treatment. Most of the patients include young teenagers as the stats as well as past studies show a noticeable ratio of occurrence of OCD in adults. Reasons include unawareness of the sign and symptoms, progression, and severity of the disease. Reasons behind unawareness are lack of acknowledgment and social stigma. Another main reason for untreated OCD is the lack of screening tools, measures, and instruments which makes OCD a misdiagnosed and poorly recognized disorder so evaluation of screening tools and their use in reducing disease burden are important areas for further research. Another reason for having such an alarming result of OCD among youth is the recent inflation that has hit the Turkish economy in the worst way. The lack of financial or social support among most of the students studying at Turkish universities has suffered people with various mental disorders and OCD is one of the prominent disorders among them. As observed in the above tables, the major group of people suffering from this ailment is 20 years to 30 years of age. Focusing on gender, it is clear that OCD is more common among females as compared to males. The possible reason is the more disturbance in the social life of a woman as compared to men. In past years, various research studies have been carried out to prove that males are less likely to suffer from OCD as compared to women. Our demographic studies have reported female predominance in prevalence which has been reported in past studies across the world [29-31]. Subjects with OCD in our study had a history of hypertension 42.6% followed by diabetes 30.5%, mental disorder 14.2%, and Tobacco smoking 12.7%. Around 51.2% of people agree that their routine activities take a long time to complete, this could lead to academic failure and occupational impairment as well. 56% of people agree that they need reassurance about their doings which could lead to a lack of self-confidence and self-esteem.
Overall study findings add to the growing evidence that OCD is common and is usually ignored which leads to a progression of the illness and Is associated with suicidal attempts. The statistics and results suggest that those people who are not fulfilling the criteria of OCD do need primary care and professional support to reduce the risk of morbidity.
Limitations
The screening of OCD was based only on the self-administered questionnaire and self-reported responses of the participants. No interview regarding the diagnosis was conducted to confirm the diagnosis. Unawareness of signs and symptoms, lack of knowledge, and lack of screening tools and measures are the reason why this common illness remains unrecognized. Therefore the estimate of prevalence might not be precise due to a lack of proper screening tools, measures, and instruments.
Conclusion
The statistics and the result of the study demonstrate that Obsessive-Compulsive disorder is taking an alarming turn as a mental disorder in the youth of Turkey and the demerit is, the lack of screening or diagnostic tools makes its determination and identification difficult which leads to a progression of the disease. Untreated OCD is more common in young females and has noticeable morbidity including suicidal thoughts. This finding is of high significance but in Turkey, it is not given that much importance as other mental illnesses such as anxiety and depression. So in nutshell, primary care health professionals and mental health professionals need to start looking at OCD as a life-threatening illness and should arrange awareness seminars and more importantly introduce proper screening tools and treatments to alleviate the spread of this life-threatening disease.
Declarations
Ethical Statement
This study has been carried out as an observational study using various questions. The request to publish the data has been sent to the ethical committee. All the participants of this study were informed before and had taken written consent to participate in this study.
Conflict of Interest
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
- Pinto, Anthony, et al. "The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake." The Journal of clinical psychiatry, Vol. 67, No. 5, 2006, p. 2146.
Google Scholar Crossref - Wilcox, Gabrielle, Frank P. MacMaster, and Erica Makarenko. "Cognitive Neuroscience Foundations for School Psychologists: Brain-Behavior Relationships in the Classroom.” Taylor & Francis, 2022.
Google Scholar - Uher, Rudolf, et al. "Screening young people for obsessive-compulsive disorder." The British Journal of Psychiatry, Vol. 191, No. 4 2007, pp. 353-54.
Google Scholar Crossref - Pardini, Dustin, et al. "The clinical utility of the proposed DSM-5 callous-unemotional subtype of conduct disorder in young girls." Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 51, No. 1, 2012, pp. 62-73.
Google Scholar Crossref - Conelea, Christine A., et al. "Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II." Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 53, No. 12, 2014, pp. 1308-16.
Google Scholar Crossref - Bloch, Michael H., et al. "Meta-analysis of the symptom structure of obsessive-compulsive disorder." American Journal of Psychiatry, Vol. 165, No. 12, 2008, pp. 1532-42.
Google Scholar Crossref - Bloch, Michael H., et al. "Meta-analysis of the symptom structure of obsessive-compulsive disorder." American Journal of Psychiatry, Vol. 165, No. 12, 2008, pp. 1532-42.
Google Scholar Crossref - Bokor, Gyula, and Peter D. Anderson. "Obsessive–compulsive disorder." Journal of pharmacy practice, Vol. 27, No. 2, 2014, pp. 116-30.
Google Scholar Crossref - Fenske, Jill N., and Ketti Petersen. "Obsessive-compulsive disorder: diagnosis and management." American family physician, Vol. 92, No. 10, 2015, pp. 896-03.
Google Scholar - Boileau, Bernard. "A review of obsessive-compulsive disorder in children and adolescents." Dialogues in clinical neuroscience, 2022.
Google Scholar Crossref - Fineberg, Naomi A., et al. "Clinical screening for obsessive-compulsive and related disorders." Israel Journal of Psychiatry and Related Sciences, Vol. 45, No. 3 2008, pp. 151-63.
Google Scholar - Hollander, Eric, Ashley Braun, and Daphne Simeon. "Should OCD leave the anxiety disorders in DSM‐V? The case for obsessive compulsive‐related disorders." Depression and Anxiety, Vol. 25, No. 4, 2008, pp. 317-29.
Google Scholar Crossref - Ozaki, N., et al. "Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype." Molecular psychiatry, Vol. 8, No. 11, 2003, pp. 933-36.
Google Scholar Crossref - Kim, S. J., et al. "Mutation screening of human 5-HT2Breceptor gene in early-onset obsessive-compulsive disorder." Molecular and Cellular Probes, Vol 14, No. 1, 2000, pp. 47-52.
Google Scholar Crossref - Stein, Dan J., et al. "Obsessive–compulsive disorder." Nature reviews Disease primers, Vol. 5, No. 1, 2019, pp. 1-21.
Google Scholar - Piras, Federica, et al. "Widespread structural brain changes in OCD: a systematic review of voxel-based morphometry studies." Cortex, Vol. 62, 2015, pp. 89-108.
Google Scholar Crossref - Radua, Joaquim, et al. "Multimodal voxel-based meta-analysis of white matter abnormalities in obsessive–compulsive disorder." Neuropsychopharmacology, Vol. 39, No. 7, 2014, pp. 1547-57.
Google Scholar Crossref - Pittenger, Christopher, Michael H. Bloch, and Kyle Williams. "Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment." Pharmacology & therapeutics, Vol. 132, No. 3, 2011, pp. 314-32.
Google Scholar Crossref - Kulkarni, Gajanan, Janardhanan C. Narayanaswamy, and Suresh B. Math. "Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia." Indian Journal of Pharmacology, Vol. 44, No. 5, 2012, p. 649.
Google Scholar Crossref - Eisen, Jane L., et al. "Impact of obsessive-compulsive disorder on quality of life." Comprehensive psychiatry, Vol. 47, No. 4, 2006, pp. 270-75.
Google Scholar Crossref - Fenske, Jill N., and Thomas L. Schwenk. "Obsessive compulsive disorder: diagnosis and management." American family physician, Vol. 80, No. 3, 2009, pp. 239-45.
Google Scholar - American Psychiatric A., et al. "Practice guideline for the treatment of patients with obsessive-compulsive disorder." 2007, pp. 5-53.
Google Scholar - Grant, Jon E. "Obsessive–compulsive disorder." New England Journal of Medicine, Vol. 371, No. 7, 2014, pp. 646-53.
Google Scholar - Perse, Teri L., et al. "Fluvoxamine treatment of obsessive-compulsive disorder." The American journal of psychiatry, 1987.
Google Scholar Crossref - Camfield, David A., Jerome Sarris, and Michael Berk. "Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence." Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, No. 4, 2011, pp. 887-95.
Google Scholar Crossref - Davidson, Joyce, and Throstur Bjorgvinsson. "Current and potential pharmacological treatments for obsessive-compulsive disorder." Expert opinion on investigational drugs, Vol. 12, No. 6, 2003, pp. 993-001.
Google Scholar Crossref - Veale, David, et al. "Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis." BMC psychiatry, Vol. 14, No. 1, 2014, pp. 1-13.
Google Scholar Crossref - Cybulska, Eva M. "Obsessive-compulsive disorder, the brain and electroconvulsive therapy." British Journal of Hospital Medicine, Vol. 67, No. 2, 2006, pp. 77-82.
Google Scholar Crossref - Rasmussen, Steven A., and Jane L. Eisen. "Epidemiology of obsessive compulsive disorder." The Journal of Clinical Psychiatry, 1990.
Google Scholar - Karno, Marvin, et al. "The epidemiology of obsessive-compulsive disorder in five US communities." Archives of general psychiatry, Vol. 45, No. 12, 1988, pp. 1094-99.
Google Scholar Crossref - Torres, Albina R., et al. "Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000." American Journal of Psychiatry, Vol. 163, No. 11, 2006, pp. 1978-85.
Google Scholar Crossref